Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1992 1
1996 3
1997 1
1998 4
2000 4
2001 1
2002 1
2003 2
2004 5
2005 7
2006 6
2007 4
2008 7
2009 3
2010 13
2011 6
2012 3
2013 1
2014 4
2015 3
2016 5
2017 10
2018 4
2019 3
2020 7
2021 7
2022 3
2023 7
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

108 results

Results by year

Filters applied: . Clear all
Page 1
KAAACI Guidelines for Allergen Immunotherapy.
Lee HY, Lee SM, Kang SY, Kim K, Kim JH, Ryu G, Min JY, Park KH, Park SY, Sung M, Lee Y, Yang EA, Jee HM, Ha EK, Shin YS, Chung EH, Choi SH, Koh YI, Kim ST, Nahm DH, Park JW, Shim JY, An YM, Han DH, Han MY, Lee YW, Choi JH; Korean Academy of Asthma Allergy and Clinical Immunology (KAAACI) Allergen Immunotherapy and Allergen Working Group. Lee HY, et al. Allergy Asthma Immunol Res. 2023 Nov;15(6):725-756. doi: 10.4168/aair.2023.15.6.725. Allergy Asthma Immunol Res. 2023. PMID: 37957792 Free PMC article. Review.
The KAAACI Guidelines for Sublingual Immunotherapy.
Min JY, Jee HM, Lee HY, Kang SY, Kim K, Kim JH, Park KH, Park SY, Sung M, Lee Y, Yang EA, Ryu G, Ha EK, Lee SM, Lee YW, Chung EH, Choi SH, Koh YI, Kim ST, Nahm DH, Park JW, Shim JY, An YM, Han MY, Choi JH, Shin YS, Han DH; on the behalf of the Korean Academy of Asthma Allergy and Clinical Immunology (KAAACI) Allergen Immunotherapy and Allergen Working Group. Min JY, et al. Allergy Asthma Immunol Res. 2024 Jan;16(1):9-21. doi: 10.4168/aair.2024.16.1.9. Allergy Asthma Immunol Res. 2024. PMID: 38262388 Free PMC article. Review.
Efficacy and safety of monotherapy with enavogliflozin in Korean patients with type 2 diabetes mellitus: Results of a 12-week, multicentre, randomized, double-blind, placebo-controlled, phase 2 trial.
Yang YS, Min KW, Park SO, Kim KS, Yu JM, Hong EG, Cho SR, Won KC, Kim YH, Oh S, Choi SH, Koh G, Huh W, Kim SY, Park KS. Yang YS, et al. Diabetes Obes Metab. 2023 Aug;25(8):2096-2104. doi: 10.1111/dom.15080. Epub 2023 Apr 24. Diabetes Obes Metab. 2023. PMID: 37016484 Clinical Trial.
Efficacy and Safety of Evogliptin Add-on Therapy to Dapagliflozin/Metformin Combinations in Patients with Poorly Controlled Type 2 Diabetes Mellitus: A 24-Week Multicenter Randomized Placebo-Controlled Parallel-Design Phase-3 Trial with a 28-Week Extension.
Moon JS, Park IR, Kim HJ, Chung CH, Won KC, Han KA, Park CY, Won JC, Kim DJ, Koh GP, Kim ES, Yu JM, Hong EG, Lee CB, Yoon KH. Moon JS, et al. Diabetes Metab J. 2023 Nov;47(6):808-817. doi: 10.4093/dmj.2022.0387. Epub 2023 Sep 26. Diabetes Metab J. 2023. PMID: 37750183 Free PMC article. Clinical Trial.
Various vascular procedures in kidney transplantations.
Moon I, Kim Y, Park J, Kim S, Koh Y. Moon I, et al. Transplant Proc. 1998 Nov;30(7):3006. doi: 10.1016/s0041-1345(98)00906-3. Transplant Proc. 1998. PMID: 9838324 No abstract available.
108 results